Short interest for Hangzhou Tigermed gives investors a sense of the degree to which investors are betting on the decline of Hangzhou Tigermed's stock. Short interest data is updated every two weeks.

Hangzhou Tigermed Stock (OTC:HNGZY), Short Interest Report

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

HANGZHOU TIGRMD UNSP/ADR by HANGZHOU TIGERMED CONSULTING CO LTD.

Hangzhou Tigermed Consulting Co Ltd

Mizuho analyst John Roberts maintains Ashland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>) with a Buy and raises the price target from $101 to $110.

News

Price Target

Analyst Ratings

Mizuho Maintains Buy on Ashland, Raises Price Target to $110

WIIM

e.l.f. Beauty shares are trading lower in sympathy with Estee Lauder, which issued weak guidance.

Cantor Fitzgerald analyst C J Muse maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Overweight and lowers the price target from $190 to $170.

Cantor Fitzgerald Maintains Overweight on Advanced Micro Devices, Lowers Price Target to $170

Market Summary

General

AMZN

Benzinga Opening Bell Update: CVS Falls 18% On Earnings Miss, Semis Drop Following Multiple Earnings In The Sector While Amazon Gains; Market Awaits Fed Decision

IDXX

IDEXX Laboratories shares are trading lower after the company reported mixed Q1 financial results and issued FY24 EPS guidance below estimates.

William Blair analyst Margaret Kaczor downgrades CVRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVRX#NASDAQ">CVRX</a>) from Outperform to Market Perform.

Downgrades

CVRX

William Blair Downgrades CVRx to Market Perform

Government

Legal

UnitedHealth Paid $22M Ransom After Hack, CEO Witty Tells Senate Committee

UTHR

United Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.

Extra Space Storage shares are trading higher after the company reported mixed Q1 financial results and issued guidance.

Wedbush analyst Moshe Katri reiterates ExlService Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXLS#NASDAQ">EXLS</a>) with a Neutral and maintains $34 price target.

Reiteration

EXLS

Wedbush Reiterates Neutral on ExlService Holdings, Maintains $34 Price Target

Guidance

NCLH

Norwegian Cruise Line Holdings Exec Says Demand For Cruise Vacations Continues To Be At All-time High; Co Is Seeing Record Book Position And Record Advanced Ticket Sales

Pseudonymous crypto trader "apatheticwhale" shared his thoughts on the success of Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) and the importance of intellectual property (IP) in the <a href="https://www.benzinga.com/topic/meme-coins">meme coin space</a>.
What Happened: The trader highlighted how Shiba Inu&#8217;s unique approach to creating its character, lore and mission differentiated it from other meme coins that simply repurposed existing memes.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24shib&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$shib</a> didn&#39;t steal an internet meme, make a token, and try to brand that token as the official token of that meme within crypto. what drew me into <a href="https://twitter.com/search?q=%24shib&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$shib</a> after it launched was that ryoshi created a new character with its own lore and mission. the original ryoshi blog posts were…
&mdash; mememillions (@apatheticwhale) <a href="https://twitter.com/apatheticwhale/status/1785459976435314843?ref_src=twsrc%5Etfw">May 1, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Apatheticwhale praised Shiba Inu&#8217;s creator, Ryoshi, for not simply stealing an internet meme, and branding a token around it. &#8220;What drew me into Shib after it launched was that Ryoshi created a new character with its own lore and mission,&#8221; the trader explained.
The original blog posts by Ryoshi were particularly compelling, according to the trader, as they established Shiba Inu as the "Doge Killer" with a mission to conquer Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>). This unique narrative and purpose resonated with the trader, who tends to be "more interested in projects that create their own world, give people a mission to believe in, and create their own unique content."
The trader also commented on the recent success of other meme coins, such as Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>) and Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>), which have adopted the strategy of repurposing older memes and branding them as the official token of the meme to attract mainstream attention.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38428112/only-dogecoin-and-shiba-inu-have-crossed-the-10b-meme-coin-mark-who-will-be-the-third-muse">Only Dogecoin And Shiba Inu Have Crossed The $10B Meme Coin Mark: &#8216;Who Will Be The Third?,&#8217; Muses Crypto Whale</a>
Why It Matters: Apatheticwhale emphasized the importance of IP in the rapidly evolving meme coin space. He adds that with the &#8220;<a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38479551/is-the-memecoin-supercycle-over-mad-crypto-alpha-with-ivan">memecoin supercycle</a>&#8221; approaching, the market is likely to face challenges related to IP owners reacting to crypto projects that have used their IP without permission.
This raises important questions about the sustainability and legal implications of building projects around existing memes.
Price Action: At the time of writing, SHIB was trading at $0.00002115, down 27% over the past 30 days. DOGE was trading at $0.1239, down 40.7% over the past 30 days.
What&#8217;s Next: The influence of meme coins and <a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a> is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:  <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38437556/dogecoin-killer-shiba-inu-burn-rate-spikes-2-092-robinhood-adds-shib-trading-for-new-york-">&#8216;Dogecoin Killer&#8217; Shiba Inu Burn Rate Spikes 2,092%, Robinhood Adds SHIB Trading For New York Residents</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

$WIF

How Did Shiba Inu Become The 'Dogecoin Killer?' Crypto Whale Thinks 'Its Mission' And This One Factor Were Key

Cencora shares are trading lower after the company reported mixed Q2 financial results.

The high-profile insider trading trial linked to Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) began in New York this Tuesday. The defendant is charged with unlawful trading in the shares of a shell company before its merger with Trump Media was announced.
What Happened: The federal criminal trial is against Bruce Garelick who is accused of insider trading, CNBC <a href="https://www.cnbc.com/2024/05/01/trump-media-insider-trading-trial-begins-in-new-york-.html">reported</a>. The first witness in the case was Andy Litinsky, a co-founder of Trump Media. Litinsky is also embroiled in complex civil litigation against former president Donald Trump over share ownership in Trump&#8217;s social media company.
It is alleged that Garelick shared non-public material information about the merger plans by the shell company, Digital World Acquisition Corp., with his boss, Florida venture capitalist Michael Shvartsman and Gerald Shvartsman, in 2021. All three men were accused of buying up DWAC stock ahead of the merger announcement based on non-public information, then selling the shares after the price soared on the heels of an announcement of the deal with Trump in October 2021.
However, Garelick&#8217;s lawyer Jonathan Bach maintains his client&#8217;s innocence, stating that Garelick did not engage in insider trading or commit any crime. He also argued that Garelick followed the rules and did not share any information about what he learned as a board member at DWAC.
See Also: <a href="https://www.benzinga.com/news/24/04/38480373/musk-vs-moskovitz-rages-on-as-tesla-ceo-trolls-facebook-co-founders-company-why-would-anyone-pay-mon?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Musk Vs. Moskovitz Rages On As Tesla CEO Trolls Facebook Co-Founder&#8217;s Company: &#8216;Why Would Anyone Pay Money For Functionality That Comes For Free On Your Phone?&#8217;</a>
Assistant U.S. Attorney Matthew Shahabian then called Litinsky to the witness stand. In his testimony, Litinsky detailed the events that led up to Trump Media&#8217;s merger agreement with DWAC. He also revealed how capricious and demanding Trump could be in the months leading up to the agreement.
Despite the ongoing trial, the defense attorney sought to draw a distinction between Garelick, who lived and worked remotely in Providence, Rhode Island, in 2021 and Michael Shvartsman, who lived and worked in the Miami area. Bach argued that Garelick &#8220;acted in good faith at all times.&#8221;
Why It Matters: The Shvartsman brothers <a href="https://www.benzinga.com/news/24/04/38083294/brothers-illegally-profited-from-trumps-media-company-using-insider-information-attorney-warns-this">admitted to their involvement</a> in a $22 million insider trading scheme linked to Trump Media &amp; Technology Group. The brothers pleaded guilty to a single count of securities fraud in federal court.
Furthermore, Trump Media has been embroiled in a<a href="https://www.benzinga.com/general/politics/24/04/38173943/trumps-public-media-company-has-6-month-share-lockup-and-its-co-founders-are-suing-so-they-can-s"> legal dispute with its co-founders</a> over the valuation of their stake in the company and dilution. The co-founders are challenging the timing to wait to sell company shares.
Price Action: On Tuesday, DJT closed at $49.93, marking a 6.94% increase since its previous close, according to <a href="https://pro.benzinga.com">Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/news/24/04/38539108/trump-says-if-supreme-court-decides-president-doesnt-get-immunity-then-biden-will-be-prosecuted-for?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Says If Supreme Court Decides President Doesn&#8217;t Get Immunity Then Biden &#8216;Will Be Prosecuted For All His Crimes&#8217;</a>
Image by mundissima via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Equities

Politics

Markets

High-Profile Insider Trading Trial Tied To Trump Media & Technology Group Kicks Off In New York

Mizuho analyst Christopher Parkinson maintains Air Products &amp; Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) with a Buy and lowers the price target from $295 to $286.

Mizuho Maintains Buy on Air Products & Chemicals, Lowers Price Target to $286

Johnson Controls shares are trading lower after the company reported mixed Q2 financial results.

Estee Lauder CFO Says Impact From Business Disruptions In Israel And Other Parts Of Middle East Was $0.01 Dilutive To EPS In Q3

VRSK

Verisk Analytics shares are trading higher after the company reported better-than-expected Q1 financial results.

Mizuho analyst Vijay Rakesh maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Buy and lowers the price target from $235 to $215.

Mizuho Maintains Buy on Advanced Micro Devices, Lowers Price Target to $215

ENTG

Entegris shares are trading lower after the company issued weak Q2 guidance.

Hangzhou Tigermed Consulting reports 1H results

Hangzhou Tigermed Consulting reports FY results

HNGZY

Press Releases

Tigermed Officially Opens International Headquarters in Hong Kong

Earnings

Tigermed Reports 2023 Interim Results

Tigermed Reports Full Year 2023 Results

Hangzhou Tigermed